Vandetanib

From Wikipedia, the free encyclopedia

Vandetanib
Systematic (IUPAC) name
N-(4-bromo-2-fluoro-phenyl)-6-methoxy-7-
[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine
Identifiers
CAS number 443913-73-3
ATC code  ?
PubChem 3081361
Chemical data
Formula C22H24BrFN4O2 
Mol. mass 475.354 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 5 days (mean)
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Vandetanib (rINN, proposed trade name Zactima), also known as ZD6474, is a medication currently undergoing clinical trials as a potential targeted treatment for non–small-cell lung cancer. It is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR).

Vandetanib is being developed by AstraZeneca.

[edit] External links